NCT02187445: Inhaled Corticosteroid Use to Prevent Acute Chest Syndrome Recurrence in Children Between 1 and 4 With Sickle Cell Disease: a Feasibility Trial |
|
|
| Completed | 1 | 36 | US | Budesonide inhalation suspension, inhaled corticosteroids | Vanderbilt University, Emory University, Children's National Research Institute | Sickle Cell Disease, Asthma, Acute Chest Syndrome | 12/16 | 02/17 | | |
